CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+18.85%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$878M
AUM Growth
+$878M
(+11%)
Cap. Flow
-$27.8M
Cap. Flow
% of AUM
-3.16%
Top 10 Holdings %
Top 10 Hldgs %
59.28%
Holding
48
New
7
Increased
7
Reduced
5
Closed
14
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$47.2M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$33.1M |
| 3 |
HCA Healthcare
HCA
|
$32.1M |
| 4 |
AstraZeneca
AZN
|
$26M |
| 5 |
Agilent Technologies
A
|
$25.6M |
Top Sells
| 1 |
VHS
VANGUARD HEALTH SYS INC COM STK (DE)
VHS
|
$41.5M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$31M |
| 3 |
AGN
Allergan plc
AGN
|
$25.2M |
| 4 |
MAKO
MAKO SURGICAL CORP COM
MAKO
|
$17.7M |
| 5 |
Universal Health Services
UHS
|
$16.7M |
Sector Composition
| 1 | Healthcare | 84.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $75.6M | 7.92% | 2,000,000 +1,250,000 | +167% | +$47.2M |
|
2
Viatris
VTRS
$12.3B
| $72.5M | 7.6% | 1,900,000 +100,000 | +6% | +$3.82M |
|
3
Elevance Health
ELV
$71.8B
| $71.1M | 7.45% | 850,000 +50,000 | +6% | +$4.18M |
|
4
Quest Diagnostics
DGX
$20.3B
| $49.4M | 5.18% | 800,000 | – | – |
|
|
VOLC
5
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $47.2M | 4.95% | 1,975,000 -225,000 | -10% | -$5.38M |
|
6
Masimo
MASI
$7.59B
| $46.6M | 4.89% | 1,750,000 | – | – |
|
7
Hologic
HOLX
$14.9B
| $46.5M | 4.87% | 2,250,000 +250,000 | +13% | +$5.16M |
|
8
Cardinal Health
CAH
$35.5B
| $39.1M | 4.1% | 750,000 | – | – |
|
9
Humana
HUM
$36.5B
| $37.3M | 3.91% | 400,000 | – | – |
|
|
MAKO
10
DELISTED
MAKO SURGICAL CORP COM
MAKO
| $35.4M | 3.71% | 1,200,000 -600,000 | -33% | -$17.7M |
|
11
CONMED
CNMD
$1.68B
| $34M | 3.56% | 1,000,000 | – | – |
|
|
MNK
12
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $33.1M | 3.47% | +750,000 | New | +$33.1M |
|
|
13
HCA Healthcare
HCA
$94.5B
| $32.1M | 3.36% | +750,000 | New | +$32.1M |
|
|
GIVN
14
DELISTED
GIVEN IMAGING LTD
GIVN
| $28.8M | 3.02% | 1,500,000 | – | – |
|
|
15
AstraZeneca
AZN
$248B
| $26M | 2.72% | +500,000 | New | +$26M |
|
|
16
Agilent Technologies
A
$35.7B
| $25.6M | 2.69% | +500,000 | New | +$25.6M |
|
17
Sarepta Therapeutics
SRPT
$1.78B
| $23.6M | 2.48% | +500,000 | New | +$23.6M |
|
|
WMGI
18
DELISTED
Wright Medical Group Inc
WMGI
| $18.5M | 1.94% | 711,000 -139,000 | -16% | -$3.63M |
|
19
AngioDynamics
ANGO
$417M
| $17.5M | 1.84% | 1,327,500 | – | – |
|
20
Novavax
NVAX
$1.21B
| $14.9M | 1.56% | 4,711,009 +1,500,000 | +47% | +$4.74M |
|
21
Arrowhead Research
ARWR
$3.05B
| $14.2M | 1.49% | 2,499,999 -614,755 | -20% | -$3.5M |
|
|
DSCI
22
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $11.8M | 1.23% | 950,000 | – | – |
|
|
GNMK
23
DELISTED
GenMark Diagnostics, Inc
GNMK
| $11.5M | 1.21% | 950,000 | – | – |
|
|
MNTA
24
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $11.5M | 1.21% | 800,000 | – | – |
|
|
MGLN
25
DELISTED
Magellan Health Services, Inc.
MGLN
| $10.5M | 1.1% | 175,000 | – | – |
|